SARS-CoV-2-Induced Remission of Chemotherapy Resistance B-Cell Non-Hodgkin Lymphoma: A Case Report
Introduction: Investigation on virus-host interaction may provide new clues for antitumor immunotherapy. Case Presentation: In this case report, we describe an unusual case of B-cell non-Hodgkin lymphoma in an aged woman who recovered following SARS-COV-2 infection. We discuss the case and suggest t...
Saved in:
| Main Authors: | Yan Xiao, Jinwei Wang, Kai Yang, Meiling Jiang, Bo Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Karger Publishers
2024-11-01
|
| Series: | Case Reports in Oncology |
| Subjects: | |
| Online Access: | https://beta.karger.com/Article/FullText/541964 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PATHOBIOLOGY OF HODGKIN LYMPHOMA
by: Claudio Agostinelli, et al.
Published: (2014-06-01) -
A clinical case of COVID-19 in a patient with Hodgkin lymphoma and brain damage
by: G. K. Zoloev, et al.
Published: (2023-04-01) -
Health of children born to women after radiation and chemotherapy for Hodgkin's lymphoma
by: A. A. Danilenko, et al.
Published: (2014-09-01) -
Evolution of drug therapy for classical Hodgkin lymphoma
by: N. Y. Samaneva, et al.
Published: (2022-09-01) -
Response and relapses in pediatric Hodgkin's Lymphoma treated with chemotherapy alone
by: Vineeta Gupta, et al.
Published: (2019-01-01)